The company's principal activity is to develop and provide economical, non-toxic methods of extending the shelf life and improving the quality of blood platelets and other biological material. The customers include blood banks, hospitals, clinics and similar organizations. The primary competitors of the company include dupont, baxter, lifecell, cerus and cryo life. The company is currently in the developmental stage.
